Close

Registration is free and only takes a moment. If you have already registered, please log in now.

Create Account
Forgot your password?
Log In
  • Links
  • Publisher Full Text
  • Authors
  • Somlo G
  • MESH
  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Combined Chemotherapy Protocols
  • Breast Neoplasms
  • Female
  • Humans
  • Receptor, erbB-2

Unbound MEDLINE

Bevacizumab in neoadjuvant treatment for breast cancer.

Links

  • Publisher Full Text
  • Authors

    Somlo G

    Source

    The New England journal of medicine 366:17 2012 Apr 26 pg 1637-8; author reply 1638-40

    MeSH

    Angiogenesis Inhibitors
    Antibodies, Monoclonal, Humanized
    Antineoplastic Combined Chemotherapy Protocols
    Breast Neoplasms
    Female
    Humans
    Receptor, erbB-2

    Pub Type(s)

    Comment
    Letter

    Language

    eng

    PubMed ID

    22533582

    Related Citations

    • Bevacizumab in neoadjuvant treatment for breast cancer.
    • Bevacizumab in neoadjuvant treatment for breast cancer.
    • Fighting fire with fire: rekindling the bevacizumab debate.
    • Pertuzumab plus trastuzumab in metastatic breast cancer.
    • Pertuzumab plus trastuzumab in metastatic breast cancer.
    • Pertuzumab plus trastuzumab in metastatic breast cancer.
    • Bevacizumab in breast cancer: the best is yet to come?
    • Bevacizumab and breast cancer: the E2100 outlier.
    More
    unbound logo
    • Home »
    • Contact Us »
    • Help »
    • Privacy / Disclaimer »
    • Terms of Service »
    • Log In »
    • twitter
    • facebook
    © 2000–2013 Unbound Medicine, Inc. All rights reserved